English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23345559      線上人數 : 500
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32308


    標題: Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion
    作者: Fang, Chia-Lang
    Uen, Yih-Huei
    Chen, Han-Kun
    Hseu, You-Cheng
    Lin, Chih-Chan
    Hung, Shih-Ting
    Sun, Ding-Ping
    Lin, Kai-Yuan
    貢獻者: Taipei Med Univ, Coll Med, Sch Med, Dept Pathol
    Taipei Med Univ, Wan Fang Hosp, Dept Pathol
    Asia Univ Hosp, Dept Surg
    Chi Mei Med Ctr, Dept Surg
    China Med Univ, Dept Cosmeceut
    Asia Univ, Dept Hlth & Nutr Biotechnol
    Chi Mei Med Ctr, Dept Med Res
    Chia Nan Univ Pharm & Sci, Dept Nutr
    Chia Nan Univ Pharm & Sci, Dept Biotechnol
    關鍵字: CDKL2
    gastric cancer
    immunohistochemistry
    prognosis
    日期: 2018-07
    上傳時間: 2019-11-15 15:49:00 (UTC+8)
    出版者: WILEY
    摘要: Cyclin-dependent kinase-like 2 (CDKL2), a new member of the cyclin-dependent kinase family, may be involved in gastric cancer (GC) progression. Thus, we conducted this study to explore the clinical effect of CDKL2 in GC. Immunohistochemistry was used to measure CDKL2 levels in gastric tissues. The association of a high CDKL2 level with clinical and pathological characteristics, and the correlation between the CDKL2 level and disease-free and overall survival were analyzed. Transfection was employed to overexpress CDKL2 in GC cells and to investigate the effect of CDKL2 overexpression on cell proliferation and invasion. Loss of CDKL2 was positively correlated with several clinical and pathological characteristics, and patients with a low CDKL2 level had significantly poorer disease-free and overall survival than those with a high level (P=.005 and .001, respectively). Univariate analysis using the Cox proportional hazards model indicated that a low CDKL2 level was a prognosticator for inferior disease-free survival (P=.007). Based on immmunoblotting data, AGS and HGC-27 GC cells were chosen for CDKL2 overexpression. Cellular studies revealed that CDKL2 overexpression impaired cell proliferation and invasion. Loss of CDKL2 may serve as a biomarker for predicting GC patient outcomes and a potential therapeutic target for GC treatment.
    link: http://dx.doi.org/10.1002/cam4.1577
    關聯: Indian Journal of Pharmaceutical Sciences, v.7, n.7, pp.2993-3002
    顯示於類別:[保健營養系(所) ] 期刊論文
    [生物科技系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    10.1002-cam4.1577.pdf749KbAdobe PDF410檢視/開啟
    index.html0KbHTML1052檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋